YOLFTbeta
00

Beijing SL Pharmaceutical Co Ltd

002038 · SHE · Healthcare / Drug Manufacturers - Specialty & Generic

5.03CNY-0.11 (-2.14%)

Price History

Full chart

Market Stats

Previous Close5.14
Open5.14
Day Range5.01 – 5.16
52-Week Range4.80 – 9.38
Volume11.30M
Market Cap5.91B
P/E (TTM)0.00
Forward P/E25.51
EPS-0.71
Dividend Yield0.18%
Beta-0.15
50-Day Avg5.87
200-Day Avg6.46

About

Beijing SL Pharmaceutical Co., Ltd., a biopharmaceutical company, research, development, and production of genetic engineering and related drugs People's Republic of China and internationally. The company's finished formulations include temozolomide; arsenic trioxide; lenalidomide capsules; paclitaxel injection; docetaxel injection; thymopentin; vinorelbine tartrate injection; hydroxyl-camptothecine; nimustine hydrochloride; asparaginase; PEG L-asparaginase; calcium foliate; recombinant human basic fibroblast growth factor; liraglutide; insulin aspart 30; insulin aspart 50; insulin aspart; dispersible; ornidazole; voriconazole; adefovir dipivoxil; levofloxacin hydrochloride; azithromycin; ribavirin; tenofovir disoproxil fumarate; valacylovir hydrochloride; lysozyme; stavudine; tropisetron hydrochloride; granisetron hydrochloride; omeprazole; coenzyme complex; ginkgo biloba extract; simvastatin; telmisartan; naftopidil; nicergoline; zaleplon; cytidine disodium triphosphate; febuxostat; filgrastim; recombinant human interleukin-11; and recombinant human interleukin-2 products. The company was formerly known as Beijing BaiLuyuan Bio-Pharmaceutical Co., Ltd and changed its name to Beijing SL Pharmaceutical Co., Ltd. in 1998. Beijing SL Pharmaceutical Co., Ltd. was founded in 1994 and is headquartered in Beijing, the People's Republic of China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEODr. Mingbo Xu Ph.D.
  • Employees901
  • HeadquartersBuilding 1, Bitongyuan, Beijing, China, 100143, China
  • Websitehttps://www.slpharm.com.cn

Leadership

  • Dr. Mingbo Xu Ph.D.Founder, Non-Independent Chairman & GM · b. 1964
  • Ms. Li JiAccounting Supervisor & Financial Manager · b. 1981
  • Ms. Shujie LiangSecretary & Non-Independent Director · b. 1966

Financials

Income Statement

Currency: CNY2001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue32.18M49.90M71.05M93.05M118.56M143.94M237.53M358.00M390.02M457.84M622.77M1.01B1.16B1.24B1.16B1.01B1.24B2.17B2.03B1.11B1.21B1.05B1.02B660.42M623.64M
Growth (%)-+55.07%+42.37%+30.96%+27.41%+21.41%+65.02%+50.72%+8.94%+17.39%+36.02%+61.70%+15.37%+6.99%-6.95%-12.68%+23.00%+74.50%-6.36%-45.18%+9.17%-13.55%-3.03%-35.15%-5.57%
Cost of Revenue4.77M11.51M20.65M32.46M45.91M53.13M81.63M49.04M66.98M106.74M153.11M335.74M381.56M374.23M394.82M353.43M366.12M450.30M419.44M167.71M183.57M156.96M188.81M212.09M236.09M
Gross Profit27.41M38.39M50.40M60.59M72.65M90.81M155.90M308.97M323.04M351.10M469.66M671.28M780.22M868.72M761.73M656.42M875.96M1.72B1.61B945.02M1.03B893.21M829.55M448.33M387.56M
Gross Margin85.17%76.93%70.94%65.12%61.28%63.09%65.64%86.30%82.83%76.69%75.41%66.66%67.16%69.89%65.86%65.00%70.52%79.22%79.34%84.93%84.89%85.05%81.46%67.89%62.14%
Operating Expense6.79M16.55M17.19M25.28M39.15M36.21M16.45M79.97M84.28M93.51M105.68M154.17M125.59M88.24M104.91M149.24M254.34M1.04B1.05B532.14M573.69M629.89M351.68M567.93M390.21M
Operating Income20.62M21.85M33.21M35.31M33.50M54.60M139.45M229.00M238.76M257.59M363.98M517.10M654.63M780.48M656.82M507.18M621.62M681.64M560.90M412.88M457.54M263.32M477.87M-119.60M-2.65M
Operating Margin64.08%43.78%46.74%37.95%28.25%37.93%58.71%63.97%61.22%56.26%58.44%51.35%56.35%62.79%56.79%50.22%50.05%31.45%27.63%37.11%37.66%25.07%46.93%-18.11%-0.42%
EBITDA20.71M-16.58M41.01M44.46M48.38M62.79M159.01M247.83M252.38M271.39M383.59M537.43M625.95M743.04M607.93M487.76M410.49M717.25M535.86M239.44M311.97M257.17M365.50M180.59M164.13M
EBITDA Margin64.35%-33.23%57.72%47.78%40.81%43.62%66.94%69.23%64.71%59.28%61.59%53.37%53.88%59.78%52.56%48.30%33.05%33.09%26.40%21.52%25.68%24.49%35.89%27.34%26.32%
Net Income18.90M19.29M31.20M32.00M33.82M47.85M134.80M217.86M244.10M272.71M523.34M481.01M577.40M695.08M575.05M452.11M533.58M571.45M486.78M364.71M425.94M234.40M416.69M-74.07M-347.20M
Net Income Margin58.74%38.66%43.91%34.39%28.53%33.24%56.75%60.85%62.59%59.57%84.03%47.77%49.70%55.92%49.72%44.77%42.96%26.36%23.98%32.78%35.06%22.32%40.92%-11.21%-55.67%
R&D------40.80M--58.18M59.88M106.83M119.77M58.79M92.56M55.02M73.68M72.89M128.35M188.64M196.15M161.65M177.11M149.62M115.40M
R&D as % of Total Revenue------17.18%--12.71%9.62%10.61%10.31%4.73%8.00%5.45%5.93%3.36%6.32%16.95%16.15%15.39%17.39%22.66%18.50%
Interest Expense85.64K2.63K5.38K64.97K2.59K14.07K17.30K27.14K5.24M47.36K62.43K514.80K111.76K138.89K108.76K17.96M18.30M1.47M1.51M585.91K459.97K315.25K66.11K52.70K-
Interest Expense % of Total Revenue0.27%0.01%0.01%0.07%0.00%0.01%0.01%0.01%1.34%0.01%0.01%0.05%0.01%0.01%0.01%1.78%1.47%0.07%0.07%0.05%0.04%0.03%0.01%0.01%-

Balance Sheet

Currency: CNY2001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets77.13M102.84M151.83M389.83M405.91M461.61M586.63M788.52M1.02B1.25B1.74B2.22B2.71B3.32B3.76B4.08B4.59B4.99B5.22B5.39B5.76B5.88B6.28B5.98B6.07B
Total Liabilities10.84M17.23M36.78M28.38M23.42M35.41M34.71M25.91M36.75M37.22M50.52M105.17M123.09M137.92M148.40M151.19M285.67M469.73M403.76M410.09M434.23M396.60M467.72M398.37M883.49M
Total Equity66.29M85.61M114.95M361.36M381.88M425.56M551.27M760.41M965.51M1.19B1.62B2.04B2.57B3.15B3.58B3.90B4.27B4.50B4.81B4.97B5.31B5.47B5.80B5.57B5.18B
Cash3.67M11.72M31.92M237.85M195.43M205.71M261.87M420.81M418.12M445.89M572.78M660.89M762.98M856.80M1.47B1.17B1.44B1.17B1.26B663.48M827.84M595.04M683.83M411.96M519.40M
Total Debt1.50M-19.21M1.00M--------1.66M1.77M----3.94M5.51M2.47M-37.59M1.26M-
Net Debt-2.17M-11.72M-12.71M-236.85M-195.43M-205.71M-261.87M-420.81M-418.12M-445.89M-572.78M-660.89M-761.32M-855.02M-1.47B-1.17B-1.44B-1.17B-1.26B-657.97M-825.37M-595.04M-683.83M-411.96M-

Cash Flow

Currency: CNY2001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow--30.55M31.26M47.48M57.55M88.36M194.32M174.41M238.13M228.59M398.60M347.41M465.00M504.87M396.86M380.72M485.17M665.83M415.84M464.63M389.82M460.20M225.49M257.66M
Investing Cash Flow---30.43M-17.76M-247.94M21.23M81.14M-18.93M-136.23M-164.43M-82.50M-248.43M-150.07M-287.00M243.51M-570.66M21.04M-415.67M-383.18M-842.14M-197.82M-540.40M-344.65M-211.55M-
Financing Cash Flow--20.09M192.43M-11.96M-3.60M-13.24M-11.45M-40.86M-45.93M-19.20M-62.64M-94.93M-94.84M-122.98M-124.15M-134.69M-342.45M-198.95M-206.92M-103.33M-102.73M-102.73M-154.10M-
Capital Expenditure0016.43M17.73M81.24M64.95M26.61M23.61M30.46M43.04M73.05M247.89M109.48M151.01M129.68M164.21M229.65M227.37M272.78M255.95M236.91M163.49M218.36M347.38M192.97M
Free Cash Flow--14.12M13.53M-33.76M-7.39M61.75M170.71M143.95M195.09M155.54M150.70M237.94M313.99M375.19M232.65M151.08M257.80M393.04M159.89M227.72M226.33M241.84M-121.89M64.69M
Dividends Paid--185.38K4.70M13.80M8.28M13.24M12.43M49.68M50.28M63.24M76.14M95.18M91.37M136.98M136.98M136.98M342.45M547.92M205.47M102.73M102.73M102.73M154.10M17.90M
FCF to OCF--46.22%43.27%-71.10%-12.85%69.88%87.85%82.54%81.92%68.04%37.81%68.49%67.52%74.31%58.62%39.68%53.14%59.03%38.45%49.01%58.06%52.55%-54.06%25.11%
Dividend Paid to FCF--1.31%34.75%-40.88%-111.98%21.44%7.28%34.51%25.77%40.66%50.52%40.00%29.10%36.51%58.88%90.67%132.84%139.40%128.51%45.11%45.39%42.48%-126.42%27.66%

Earnings

Report DateJul 27, 2009Jun 2, 2010Sep 1, 2010Dec 1, 2010Mar 2, 2011Jun 1, 2011Aug 31, 2011Nov 30, 2011Feb 29, 2012May 30, 2012Aug 29, 2012Nov 28, 2012Feb 27, 2013Apr 17, 2013Aug 15, 2013Nov 27, 2013Feb 27, 2014May 28, 2014Aug 19, 2014Oct 23, 2014Mar 1, 2015Apr 27, 2015Aug 23, 2015Oct 29, 2015Feb 29, 2016Apr 25, 2016Aug 26, 2016Oct 26, 2016Feb 27, 2017Apr 27, 2017Aug 29, 2017Oct 26, 2017Feb 26, 2018Apr 25, 2018Aug 28, 2018Oct 29, 2018Feb 27, 2019Apr 23, 2019Aug 26, 2019Oct 27, 2019Feb 27, 2020Apr 30, 2020Aug 25, 2020Oct 29, 2020Feb 26, 2021Apr 27, 2021Aug 27, 2021Oct 29, 2021Apr 28, 2022Aug 24, 2022Oct 26, 2022Apr 26, 2023Aug 24, 2023Oct 26, 2023Dec 31, 2023Apr 23, 2024Aug 25, 2024Oct 26, 2024Apr 23, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate0.08------------0.120.19-0.20--0.19-0.18-0.20-0.23-0.16-0.170.13----0.15----------------0.080.060.020.020.11-------
EPS Actual0.070.060.080.060.070.070.270.090.080.100.120.120.130.130.140.140.100.160.180.150.160.160.190.150.060.080.100.090.090.100.090.150.140.180.160.180.050.200.150.14-0.020.060.130.100.050.090.200.13-0.010.100.070.200.100.010.030.030.02-0.05-0.060.070.02-0.48-0.08-0.16
Surprise-12.50%------------8.33%-26.32%--50.00%---21.05%--11.11%--25.00%--65.22%--43.75%--41.18%-30.77%----20.00%----------------25.00%-83.33%50.00%50.00%-81.82%-------
TimingAfter-hours------------After-hoursAfter-hours-After-hours-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursPre-market---Pre-market---After-hours--After-hoursAfter-hours-------

Key Statistics & Ratios

Market Cap5.91B
Enterprise Value4.70B
Trailing P/E0.00
Forward P/E25.51
PEG Ratio0.67
Price / Sales10.36
Price / Book1.21
EPS-0.71
Book Value4.80
Revenue (TTM)570.26M
Gross Profit (TTM)348.31M
EBITDA144.90M
Profit Margin-126.84%
Operating Margin-30.75%
Return on Equity-13.63%
Return on Assets-0.25%
Shares Outstanding1.03B
Shares Float629.34M
Beta-0.15
Dividend Yield0.18%
Dividend Rate0.01
Payout Ratio0.00%

Dividends

20261×
0.01Jul 22, 2026
20251×
0.02Jul 4, 2025
20241×
0.15Jul 4, 2024
20231×
0.10Jun 28, 2023
20221×
0.10Jun 29, 2022
20211×
0.10Jul 7, 2021
20201×
0.20Jul 8, 2020
20191×
0.20Jul 4, 2019
20181×
0.33May 4, 2018
20171×
0.13Jul 5, 2017
20161×
0.13Jul 22, 2016
20151×
0.13Jul 15, 2015
20141×
0.09Jul 4, 2014
20131×
0.09May 28, 2013
20121×
0.07Jul 20, 2012
20111×
0.06Apr 27, 2011
20101×
0.05May 31, 2010
20091×
0.05Jun 10, 2009
20081×
0.01May 9, 2008
20071×
0.01Apr 18, 2007
20061×
0.01Jun 1, 2006
20051×
0.01Apr 19, 2005

Stock Splits

  • Jul 4, 20191.5:1
  • Jul 15, 201515:10
  • May 28, 20131.2:1
  • Apr 27, 201115:10
  • May 9, 20082:1
  • Apr 18, 200715:10
  • Apr 19, 200512:10